The United States Patent & Trademark Office's Current View on Patent Eligibility

Abstract

Get full access to this article

View all access options for this article.

References

Fraser

, Rosen

. Patenting genes in a post-Myriad world. Ind Biotechnol, 2013; 9(4):163–164.

Reiter

, Fasse

JP.

Patent eligibility of biological methods and compositions. Ind Biotechnol, 2013; 9(3):90–92.

Mayo Collaborative Servs. v. Prometheus Labs., Inc., 566 U.S. __, 132 S. Ct. 1289 (2012).

Assoc. for Molecular Pathology v. Myriad Genetics, Inc., 569 U.S. __, 133 S. Ct. 2107, 2111 (2013).

Guidance for Determining Subject Matter Eligibility of Claims Reciting Or Involving Laws of Nature, Natural Phenomena, & Natural Products. Citing Diamond v. Chakrabarty , 447 U.S. 303 (1980) and Myriad, 133 S. Ct. at 2116-17. Available at www.uspto.gov/patents/law/exam/myriad-mayo_guidance.pdf (Last accessed May 2014 ).

Guidance for Determining Subject Matter Eligibility of Claims Reciting Or Involving Laws of Nature, Natural Phenomena, & Natural Products at pg 3. Available at www.uspto.gov/patents/law/exam/myriad-mayo_guidance.pdf (Last accessed May 2014 ).